Novel Bispecific Aptamers for Treating Retinal Disease
NCBiotech Grants & Loans
See the full listing of all NCBiotech grants and loans awarded since July 2012.
Organization
Drive Therapeutics, LLC
Award Date
Award Amount
100,000
Program Name
Small Business Research Loan
Program Category
Business Financing
Principal Investigator
Douglas Gooding
Fiscal Year
2021
Region
Research Triangle
Project Description:
Drive Therapeutics is developing a novel, long-acting, bispecific, and immune targeted nucleic acid therapy to block angiogenesis, inflammation, and fibrosis underlying retinal disease. The company was awarded a SRL to optimize and characterize lead candidate aptomers for the treatment of wet-age related macular degeneration and diabetic macular edema retinal diseases.